Is NCT03160040 results overdue?

Yes — results are overdue. Primary completion was 2018-05-01; the FDAAA-801 reporting deadline (2019-05-01) passed 2654 days ago and no results are posted on ClinicalTrials.gov.

A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin® (Minocycline) for Infections Caused by Gram-negative Bacteria in a Real World Setting

NCT ID	NCT03160040 ↗
Sponsor	Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) (INDUSTRY)
Phase	—
Status	COMPLETED
Primary completion	2018-05-01 (ACTUAL)
Reporting deadline	2019-05-01 (completion + 365d)
Days overdue	2654
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `9db200e631708811…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03160040. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.